Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma.
Anichini G, Raggi C, Pastore M, Carrassa L, Maresca L, Crivaro E, Lottini T, Duwe L, Andersen JB, Tofani L, Di Tommaso L, Banales JM, Arcangeli A, Marra F, Stecca B. Anichini G, et al. Among authors: di tommaso l. Mol Cancer Ther. 2023 Mar 2;22(3):343-356. doi: 10.1158/1535-7163.MCT-22-0379. Mol Cancer Ther. 2023. PMID: 36807728 Free PMC article.
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.
Raggi C, Correnti M, Sica A, Andersen JB, Cardinale V, Alvaro D, Chiorino G, Forti E, Glaser S, Alpini G, Destro A, Sozio F, Di Tommaso L, Roncalli M, Banales JM, Coulouarn C, Bujanda L, Torzilli G, Invernizzi P. Raggi C, et al. Among authors: di tommaso l. J Hepatol. 2017 Jan;66(1):102-115. doi: 10.1016/j.jhep.2016.08.012. Epub 2016 Sep 1. J Hepatol. 2017. PMID: 27593106 Free PMC article.
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells.
Gentilini A, Caligiuri A, Raggi C, Rombouts K, Pinzani M, Lori G, Correnti M, Invernizzi P, Rovida E, Navari N, Di Matteo S, Alvaro D, Banales JM, Rodrigues P, Raschioni C, Donadon M, Di Tommaso L, Marra F. Gentilini A, et al. Among authors: di matteo s, di tommaso l. Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2246-2256. doi: 10.1016/j.bbadis.2019.04.020. Epub 2019 May 3. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31059778 Free article.
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma.
Raggi C, Fiaccadori K, Pastore M, Correnti M, Piombanti B, Forti E, Navari N, Abbadessa G, Hall T, Destro A, Di Tommaso L, Roncalli M, Meng F, Glaser S, Rovida E, Peraldo-Neia C, Olaizola P, Banales JM, Gerussi A, Elvevi A, Droz Dit Busset M, Bhoori S, Mazzaferro V, Alpini G, Marra F, Invernizzi P. Raggi C, et al. Among authors: di tommaso l. Am J Pathol. 2019 Oct;189(10):2090-2101. doi: 10.1016/j.ajpath.2019.06.007. Epub 2019 Jul 24. Am J Pathol. 2019. PMID: 31351075 Free article.
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C, Taddei ML, Sacco E, Navari N, Correnti M, Piombanti B, Pastore M, Campani C, Pranzini E, Iorio J, Lori G, Lottini T, Peano C, Cibella J, Lewinska M, Andersen JB, di Tommaso L, Viganò L, Di Maira G, Madiai S, Ramazzotti M, Orlandi I, Arcangeli A, Chiarugi P, Marra F. Raggi C, et al. Among authors: di maira g, di tommaso l. J Hepatol. 2021 Jun;74(6):1373-1385. doi: 10.1016/j.jhep.2020.12.031. Epub 2021 Jan 21. J Hepatol. 2021. PMID: 33484774 Free article.
Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
Gentilini A, Lori G, Caligiuri A, Raggi C, Di Maira G, Pastore M, Piombanti B, Lottini T, Arcangeli A, Madiai S, Navari N, Banales JM, Di Matteo S, Alvaro D, Duwe L, Andersen JB, Tubita A, Tusa I, Di Tommaso L, Campani C, Rovida E, Marra F. Gentilini A, et al. Among authors: di maira g, di matteo s, di tommaso l. Hepatology. 2021 Oct;74(4):2007-2020. doi: 10.1002/hep.31888. Epub 2021 Jul 5. Hepatology. 2021. PMID: 33959996 Free PMC article.
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M, Cappon A, Pastore M, Piombanti B, Lori G, Oliveira DVPN, Munoz-Garrido P, Lewinska M, Andersen JB, Coulouarn C, Sulpice L, Peraldo Neia C, Cavalloni G, Quarta S, Biasiolo A, Fassan M, Ramazzotti M, Parri M, Recalcati S, di Tommaso L, Campani C, Invernizzi P, Torzilli G, Marra F, Pontisso P, Raggi C. Correnti M, et al. Among authors: di tommaso l. Liver Int. 2022 Jan;42(1):233-248. doi: 10.1111/liv.15049. Epub 2021 Sep 16. Liver Int. 2022. PMID: 34478594 Free PMC article.
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization.
Porro N, Spínola-Lasso E, Pastore M, Caligiuri A, di Tommaso L, Marra F, Gentilini A. Porro N, et al. Among authors: di tommaso l. Cancers (Basel). 2024 Dec 19;16(24):4239. doi: 10.3390/cancers16244239. Cancers (Basel). 2024. PMID: 39766138 Free PMC article. Review.
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target.
Alvisi G, Termanini A, Soldani C, Portale F, Carriero R, Pilipow K, Costa G, Polidoro M, Franceschini B, Malenica I, Puccio S, Lise V, Galletti G, Zanon V, Colombo FS, De Simone G, Tufano M, Aghemo A, Di Tommaso L, Peano C, Cibella J, Iannacone M, Roychoudhuri R, Manzo T, Donadon M, Torzilli G, Kunderfranco P, Di Mitri D, Lugli E, Lleo A. Alvisi G, et al. Among authors: di tommaso l, di mitri d. J Hepatol. 2022 Nov;77(5):1359-1372. doi: 10.1016/j.jhep.2022.05.043. Epub 2022 Jun 20. J Hepatol. 2022. PMID: 35738508
275 results